简介内容：Gemcitabine-ibandronate (GEM–IB), a conjugate of gemcitabine (GEM)-5´-phosphate with ibandronate (IB), exhibits efficacy both as a monotherapy and synergistically with Docetaxel (DTX), resulting in diminished tumor burden, maintained bone structure, and enhanced survival in a murine osteosarcoma (OS) model [1].
Customer Service
